A B S T R A C T To study the effect of streptozotocin induced diabetes on glomerular basement membrane (GBM) synthesis, an isolated rat glomerular preparation has been developed, and its metabolic properties have been defined. The chemical composition of normal rat GBM isolated from this preparation closely resembles human GBM. Incubation with [U-'4C1 lysine leads to prompt incorporation of label into GBM and the subsequent appearance of labeled hydroxylysine. A 1-h lag before detection of labeled hydroxylysine in GBM suggests a delay in the release of GBM precursors. Significantly lower counts appeared in the nondialyzable fraction of the medium than in insoluble GBM during pulse-chase experiments, and labeled hydroxylysine accounted for a lower portion of the total counts in the medium (0.85%) than in the GBM (1.98%).
INTRODUCTION
Pathologic changes in the capillary wall characterized by thickening of the basement membrane have been recognize(l in multiple vascular beds of long-term diabetics (1, 2) . Diabetic intercapillary glomerulosclerosis and restultant renal failure, however, continue to be the greatest single cause of mortality and morbidity in patients with the juvenile onset type of diabetes (3, 4) . This lesionl, first described by Kimmelstiel and Wilson (5) , represents the most specific diabetic microvascular lesion, althouglh diffuse thickening of the glomerular basement membrane (GBM)' occurs with equal or greater frequency (6, 7) . Glomerular lesions resembling those seen in human diabetes have also been described in experimental animals with both genetic (8, 9) and experimental diabetes (10) (11) (12) (13) suggesting that environmental factors may play a role in their pathogenesis. For example. recent electron microscopic studies have demonstrated that modest basement membrane thickening occurs in the GBM of rats with long-term streptozotocin induced diabetes (13) . This and other studies lAbbreviation itsed in this paper: GBM, glomerular basement membrane.
The Journal of Clinical Investigation Volume 58 October 1976-844-852 imply that rats with experimental diabetes may serve as a useful model for the study of human diabetic microangiopathy.
In addition to the basement membrane thickening observed in patients with diabetes mellitus, a distinct chemical change has been described in the GBM of some patients with diabetes of long duration (14, 15) . The diabetic GBM shows an increase in hydroxylysine with a concomitant decrease in lysine residues as well as an increase in the disaccharide glucosyl-galactose covalently bound to hydroxylysine. In addition, significant increases in GBM hydroxyproline and glycine content and decreases in valine and tyrosine are also observed in diabetic GBM. Since a subunit rich in glucosyl-galactose, hydroxylysine, glycine, and hydroxyproline and poor in lysine, valine, and tyrosine has been described in bovine GBM (16) , it is possible that the change in diabetic GBM could represent accumulation of a similar carbohydrate rich subunit. No information on the chemical composition of GBM in experimental animals with longterm diabetes is currently available.
Our current information regarding the control of GBM biosynthesis is inadequate. Several studies which utilized experimental animals have suggested that the thickening of basement membrane in diabetes is due to accelerated synthesis. By utilizing alloxan diabetic rats, Spiro and Spiro (17) have demonstrated increased activity of renal glucosyl transferase. the enzyme that adds the terminal glucose residue to the glucosyl-galactose disaccharide in GBM. In another study Cohen and Vogt (18) have suggested that glomeruli isolated from pancreatectomized rats incorporate increased amounts of labeled lysine into a subcellular fraction, and more recently Khalifa and Cohen (19) have demonstrated increased glomerular lysyl hydroxylase activity in streptozotocin diabetic rats. Wahl and his colleagues, on the other hand, could not demonstrate increased incorporation of labeled glucose into GBM when glomeruli from alloxan diabetic animals were compared with nondiabetics (20) .
To study GBM biosynthesis an isolated rat glomerular preparation has been developed, and its metabolic parameters have been defined. The viability and metabolic properties of isolated glomeruli have previously been documented by several other investigators (20) (21) (22) (23) (24) . The incorporation of [U-'4C] lysine into GBAI by this preparation provides information on the rates of GBEI biosynthesis. The subsequent incorporation of labeled hydroxylysine residues into GBM indicates that in addition to providing information on GBMI synthesis this preparation may furnish useful data on lysyl hydroxylase activity. This enzyme is of special interest since hydroxylation of lysine residues presumably precedes the addition of galactose and glucose residues to GBM (25) . By utilizing this preparation, glomeruli which have been isolated from normal and streptozotocin diabetic animals, have been studied to determine their rates of incorporation of labeled lysine and hydroxylysine into GBM.
To determine the effect of long-term experimental diabetes on the chemical composition of the GBM, streptozotocin diabetic rats and age matched controls have been maintained for 14 mo before isolation and chemical analysis of their GBM. Information obtained from these experiments is necessary to evaluate the results of the GBM biosynthetic studies and provides useful information on the relative role played by genetic and environmental factors in the pathogenesis of diabetic microangiopathy. (15, 26) . Because of the smaller size of rat glomeruli, the cortical tissue was disrupted in 5-g portions with the bottom of a 150-ml beaker on 3-inchi 150-mesh sieves. The suspension of material passing through this sieve was in turn passed through a 150-mesh sieve in series with a 200-mesh sieve, and the glonieruli on the 200-mesh sieve were washed two times wvitlh 75 ml of 0.9% sodium chloride (pH = 7.40) and transferred for centrifugation at 12,000 g at 4°C. The pellet was suspended in Krebs-Ringers bicarbonate buffer, and samples were taken for incubation and nitrogen determination. The preparations consistently contained greater than 95% glomeruli when differential counts were performed by phase microscopy. washed with cold 1.0 N NaCl and distilled water as previously described (15) . Hydrolysis was performed in 6.0 N constant boiling HCl under nitrogen at 105°C for 24 h, and the acid was removed under vacuum at 50°C.
METHODS
The component amino acids were separate(l by ion exchange chromatography using the short column of the Beckman model 120C Amino Acid Analyzer (Beckman Instruments, Inc., Fullerton, Calif.). Two-thirds of the effluent was diverted by a stream splitter to a fraction collector for scintillation counting, while amino acid composition was determined with the remaining one-third. 1-ml saml)les of the effluent were counite(d in Aquasol ( New England Nuclear, Boston, Mass.) by utilizing the liquid scintillation spectrometer. Counts wvere considered significant if they fell outside the 99%7 confidence limits calculated for backgroun(d by a method described by Steinberg and Udenifriend (29) .
The nitrogen content of the basement membrane was determined after solubilization of a sample of GBM in 0.1 N NaOH at 37°C and digestion with 50% H2SO4 (26) . The amount of (Iry GBM was determineed for each p)reparation by usinlg a nitrogen content of 9.65%e as determined by digestion of GBMI of known composition. The 10 normal rats, a 1-h pulse with ['4C]lysine (312 mCi/nmol) was followed by a 3-h chase period in Krebs-Ringers bicarbonate containing 5 mM glucose and 0.25 mM lysine. Incubations were performed at 37°C as previously described. After terminating the incubation by addition of a,a'-dipyridyl and cyclohexamide to achieve concentrations of 1.0 mM and 100 Ag/ml, respectively, the samples were spun at 15,000 g at 4°C and the media from the two incubations were pooled. The medium was extensively dialyzed against 2.5 nmIM L-lysine in distilled water at 4°C until constant specific activity was achieved. The dialysate was then taken to dryness in an Evap-o-Mix (Rotary Evapo-Mix, Buchler Instruments, Div. Searle Analytic, Inc., Fort Lee, N. J.) at 30°C and hydrolyzed under nitrogen in constant boiling 6.0 N HCl at 105°C for 24 h. Counts were determined on fractions corresponding to lysine and hydroxylsine as previously described.
GBMA comizpositiont in lontg-termn diabetic antimawls. 
RESULTS
The amino acid composition of GBM isolated from control rats closely resembles that of normal human (14, 31, 32) and bovine (33) GBM (Table I ) and is similar to that found in prior studies of rat GBM (34, 35) . Analysis of the carbohydrate content of rat GBM revealed the presence of glucose, galactose, mannose, fucose, and glucosamine (Table II) , all of which have previously been found in human and bovine GBM.
Incubations of glomeruli with [U-24C] glucose for 6 h led to the linear production of "4CO2 indicating viability for this period of time. In two experiments the glomeruli produced 3.12 and 4.26 ,Amoles of lactate/i00 mg When glomeruli are incubated with [U-14C] lysine for variable periods up to 4 h, significant amounts of labeled lysine appear in GBM within 20 min, and after 1 h the increase of labeled lysine in GBM remains roughly linear for the duration of the incubation (Fig. 1) . Significant levels of labeled hydroxylysine were not detected in GBM, however, for 60 min after addition of perforflled. Normal glomiieruli were exposed to a 1-h pulse of labeled lysine, followed by a 1-3 h chase with 0.25 mM L-lysine. [U-'4C] lysine levels in GBM increased progressively up to 1 h after initiation of the chase period, after which labeled lysine content remained constant (Fig. 2) . During the chase period the GBM content of labeled hydroxylvsine increased in a roughly linear fashion. In addition to the lysine and hydroxylysine fractions, counts were determined on the effluent from the amino acid analyzer corresponding to the acidic, neutral, and other basic amino acids of GBM.
No significant radioactivitv was detected in these fractions, indicating that no interchange of label between lysine or hydroxvlvsine and other amino acids occurred during GBM synthesis.
Preliminary experiments were also performed to determine if [U-YC] lysine and hydroxylysine appeared in the nondialyzable fraction of the medium during pulse-chase experiments. By utilizing glomeruli from normal rats, the counts above base line appearing in lysine and hydroxylysine of the nondialyzable fraction of the medium were 9.992 and 86 cpm, respectively, after a 3-h chase period. The total counts above base line found in lysine and hydroxylysine of the insoluble GBM during the same time period were 31,331 and 632 cpm, respectively. The values for counts in intact GBAI are considerably higher than those detected in the medium. In addition, the proportion of lysine residues hydroxylated in insoluble GBM ( 
GBM.
To evaluate the effects of experimental diabetes on the incorporation of lysine and hydroxylysine containing precursors into the glomerular basement membrane, male Wistar rats were made diabetic with streptozotocin (37) . Animals were considered diabetic if their plasma glucose levels consistently exceeded 300 mg/100 ml. Diabetics and age matched controls injected with buffer alone were maintained for 4-6 wk. None of the diabetic animals became ketotic, and, as expected, the weight gain of the diabetic animals (50.7±5.74 g) was signifi-cantly less than that of their controls (127.1±10.24 g). Glomeruli isolated from 10 to 12 diabetic or normal animals were used for each experiment. The basement membrane isolated from 10 groups of 20 diabetic animals each and control groups of similar size were analyzed for yield and lysine content. The yield of basement membrane from the glomeruli of diabetic animals expressed as dry weight of basement membrane per wet weight cortex did not differ significantly from that of controls (Table IV) . The lysine content of the basement membrane from diabetic animals was also similar to that found in controls (Table IV) .
Glomeruli from diabetic animals were incubated with uniformly labeled ["4C] lysine for 4 h, a time at which the apparent rate of lysine incorporation into normal basement membrane approaches linearity. As seen in Table V , the glomeruli from diabetic animals did not differ from controls in their capacity to incorporate labeled lysine into the glomerular basement membrane. To study the effect of diabetes on incorporation of hydroxylysine residues into GBM, pulse-chase experiments were performed utilizing glomeruli from diabetic animals. As can be seen in Table VI , the label found in basement membrane hydroxylysine after a 3-h chase with cold lysine was similar when glomeruli from diabetic animals were compared with age matched controls.
The [U-"C] lysine content of the GBM from diabetic animals also did not differ from that seen in controls (Table VI) . Similar results were found when incorporation of labeled lysine and hydroxylysine were expressed as specific activities based on GBM lysine or hydroxylysine content rather than the dry weight of GBM. I Meani±SEM. 4 .87±0.71 vs. diabetic 4.90±1.07 nmol/mmol GBM hydroxylysine, P for both = NS).
Compositional studies performed on GBM from longterm diabetic rats (14 mo) are compared with GBM from age matched controls in Table I and II. Except for minor differences in proline and arginine content, the amino acid composition of GBM isolated from diabetic animals did not differ from controls. In addition, the carbohydrate content of the GBM from diabetic rats did not differ from that seen in controls. The similarities in GBM glucose content, a sugar found only in the disaccharide glucosyl-galactose, and in mannose and glucosamine, both of which are found only in the larger heteropolysaccharide, suggest that the content of these two subunits is unchanged in GBM from diabetic rats.
Representative samples from diabetic and control rat kidneys were examined by light microscopy by Dr. Joseph Williamson. Examination of samples stained with haematoxylin and eosin and periodic acid Schiff reagents revealed no difference between the diabetic and control tissues. Some increase in the mesangial area and mild thickening of peripheral capillary loops was noted in diabetic tissues, but age matched control kidneys showed similar changes. Similar histologic changes have previously been noted in association with aging alone in man and other species (38, 39) . lysine into GBM proceeds in a linear fashion. Pulsechase experiments demonstrate that a 60-min interval occurs before significant counts appear in GBM hydroxylysine, suggesting a delay in the release of hydroxylysine containing GBM precursors similar to that noted in the biosynthesis of interstitial collagens and other basement laminae (36, 40, 41) . Once hydroxylated lysyl residues are detected in GBM, there is a progressive linear increase in labeled hydroxylysine for the duration of the incubation. In pulse-chase experiments this occurs without a further increase in labeled lysine, raising the possibility that incorporation of lysyl residues into a GBM precursor precedes hydroxylation. Conversely, the small percentage of labeled lysyl residues hydroxylated after a 4 h incubation ( Fig. 1) relative to the proportion of lysine residues subsequently hydroxylated in rat GBM ( Table I ) could indicate that the hydroxylysine rich precursor accounts for a relatively small proportion of the newly synthesized GBM, as suggested by Grant et al. (36) . This could also reflect the slow turnover of GBM previously noted by several investigators (42. 43) .
Pulse-chase experiments performed with glomeruli from diabetic animals demonstrated no significant change in the incorporation of labeled hydroxylysine into the GBM when compared witlh controls. This probably represents equal rates of deposition of hydroxylysine containing GBM precursor into insoluble GBM by diabetic and control tissues (36, 40) , although little information is available regarding the characterization of precursors accounting for the bulk of GB.NM synthesis. The production of equal amounts of hydroxylysine containing precursors by diabetic and normal glomeruli also suggests normal activity of lysyl hydroxylase in the diabetics, although increased intracellular levels of newly hydroxylated GBM precursors cannot be excluded.
Several recent studies, utilizing embryonic chick lens (36) and the embryonic rat parietal yolk sac (40) have demonstrated the production of a soluble collagen-like basement membrane precursor when these tissues are incubated with labeled proline or lysine. In these metabolically active tissues as in isolated glomeruli. the basement membrane precursor accounts for only a small proportion of newly labeled soluble protein. The preliminary studies reported here indicate that counts in both lvsine and hydroxylysine in insoluble GBM exceed those in the medium during incubations performed with isolated glomeruli. suggesting that under these experimental conditions the quantification of label in a soluble GBM precursor rather than insoluble GBM would not be a more sensitive indicator of GBM synthesis. Information gained with embryonic tissues is of great interest, although it has yet to be established that these tissues are subject to the same metabolic controls found in glomeruli from more mature animals. In addition, it would be different to utilize embryonic tissues for longterm studies of the pathogenesis of basement membrane thickening which characteristically occur over months to years. The recent studies of Grant et al. (44) (17) . Unfortunately, renal galactosyl transferase, the enzyme which adds the initial sugar residue to hydroxylysine, did not demonstrate sufficient activity to allow comparison in diabetic and normal animals. In addition, the prompt glycosylation of newly hydroxylated lysyl residues demonstrated in more recent biosynthetic studies of the basement membrane of chick lens suggests that lysine hydroxylation is the step where regulation may limit GBM synthesis and extrusion from cell (36) . Cohen and Vogt (18) have demonstrated increased incorporation of labeled lysine into glomerular proteins by glomeruli isolated from streptozotocin diabetic rats and more recently Khalifa and Cohen (19) have presented evidence suggesting increased lysyl hydroxylase activity in the soluble fraction of homogenates from diabetic animals. Wahl and his colleagues, however, were unable to demonstrate increased incorporation of labeled glucose into the GBM in studies utilizing glomeruli from diabetic rats (20) . Considerable confusion exists regarding the relationship of the metabolic changes associated with diabetes to the progression of diabetic microvascular disease. The present study suggests that chronic streptozotocin induced diabetes is not associated with changes in the biosynthesis, chemical composition, or morphology of the GBM. Biosynthetic (18, 19) and compositional (14, 15, 47) studies in both experimental animals and diabetic patients, however, have suggested that hyperglycemia, insulin deficiency, or other metabolic abnormalities associated with diabetes may play an important role in the progression of diabetic capillary disease. The application of newer biochemical (44) and more rigorous morphometric techniques (48, 49) may eventually provide information on the role played by environmental and hereditary factors in the pathogenesis of diabetic microvascular disease.
